Skip to main content
. 2018 May 28;10:138. doi: 10.3389/fnagi.2018.00138

FIGURE 1.

FIGURE 1

The distribution in percentage of AD and NAD patients in the two cohorts (A: MTP-1 and B: MTP-2) when classified using the PLM-scale or the PLMR scale. Note important shift in the distribution of the AD patients between the two scales (ANOVA, p < 0.0001, PLM-AD vs. PLMR-AD).